Suppr超能文献

亚催眠剂量丙泊酚对志愿者胃排空的影响。

Effects of subhypnotic doses of propofol on gastric emptying in volunteers.

作者信息

Chassard Dominique, Lansiaux Sabine, Duflo Frédéric, Mion François, Bleyzac Nathalie, Debon Richard, Allaouchiche Bernard

机构信息

Service d'Anesthésie-Réanimation, Hôpital de l' Hôtel-Dieu, Lyon, France.

出版信息

Anesthesiology. 2002 Jul;97(1):96-101. doi: 10.1097/00000542-200207000-00014.

Abstract

BACKGROUND

Drugs which accelerate gastric emptying (GE) decrease nausea and vomiting. This could contribute to the antiemetic potential of subhypnotic doses of propofol. On the contrary, subhypnotic doses of propofol used for sedation could decrease GE and thus favor regurgitation and pulmonary inhalation. Therefore, the aim of this study was to assess the effect of low-dose propofol infusion on GE.

METHODS

On three separate occasions, 10 volunteers received either a propofol infusion at a rate set to achieve a target plasma concentration of 0.5 microg/ml or equivalent volumes of 10% Intralipid(R) or 0.9% saline. GE for solids was measured by using the octanoic acid breath test. An acetaminophen absorption technique measured the GE rate for liquids. Blood samples were assayed for acetaminophen and propofol. Breath samples were analyzed for (13)CO(2) concentration by isotope-ratio mass spectrometry. Carbon dioxide production (VCO(2)) was measured instead of calculated by indirect calorimetry. Sedation was evaluated by the Bispectral Index of the electroencephalogram.

RESULTS

Propofol blood concentrations were 0.32 +/- 0.20 and 0.45 +/- 0.18 microg/ml at 60 and 165 min, respectively. These concentrations were not sedative. Propofol or its solvent did not modify GE for solids or liquids. In all groups, differences in GE were obtained if measured VCO(2) was integrated in the formula instead of calculated VCO(2) (P < 0.002).

CONCLUSIONS

Subhypnotic doses of propofol known to be antiemetic do not inhibit GE. These results suggest that the antiemetic properties of propofol are not peripheral and that propofol cannot be considered as a prokinetic agent. V(13)CO(2) must be measured instead of calculated to accurately determine GE.

摘要

背景

加速胃排空(GE)的药物可减轻恶心和呕吐。这可能有助于亚催眠剂量丙泊酚的止吐作用。相反,用于镇静的亚催眠剂量丙泊酚可能会降低胃排空,从而增加反流和肺吸入的风险。因此,本研究的目的是评估低剂量丙泊酚输注对胃排空的影响。

方法

10名志愿者在三个不同的时间分别接受以设定速率输注丙泊酚以达到目标血浆浓度0.5微克/毫升,或等量的10%英脱利匹特(R)或0.9%生理盐水。通过辛酸呼气试验测量固体的胃排空。对乙酰氨基酚吸收技术测量液体的胃排空速率。检测血样中的对乙酰氨基酚和丙泊酚。通过同位素比质谱法分析呼气样本中的(13)CO(2)浓度。通过间接量热法测量而不是计算二氧化碳产生量(VCO(2))。通过脑电图的双谱指数评估镇静程度。

结果

丙泊酚血药浓度在60分钟和165分钟时分别为0.32±0.20和0.45±0.18微克/毫升。这些浓度不具有镇静作用。丙泊酚或其溶剂未改变固体或液体的胃排空。在所有组中,如果将测量的VCO(2)纳入公式而不是计算的VCO(2),则胃排空会有差异(P<0.002)。

结论

已知具有止吐作用的亚催眠剂量丙泊酚不会抑制胃排空。这些结果表明丙泊酚的止吐特性不是外周性的,并且丙泊酚不能被视为促动力药物。必须测量而不是计算V(13)CO(2)以准确确定胃排空。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验